Navigation Links
Leading Blood Centers, LifeSource and Central Blood Bank, Spotlight a Unique Donor Population During National Hereditary Hemochromatosis Awareness Month
Date:7/14/2009

symptoms related to HH before it causes problems. Although the majority of patients are diagnosed after age 40, the availability of genetic testing allows diagnosis of individuals at a younger age.

Males are five times more likely than females to be diagnosed with the disease due to menstruation, pregnancy, lactation, or lower iron intake. Symptoms usually appear between ages 40 and 60 when the iron build-up in the body has already reached toxic levels, causing irreparable damage to internal organs.

"After testing positive for the HFE mutation, I was quickly diagnosed with HH," says patient Christopher Jansen. "My doctor wrote me a prescription for regular phlebotomy treatments which I began at LifeSource. With health care costs on the rise, I was surprised that I could receive these ongoing treatments for free. Almost a year later I continue to have phlebotomy done at LifeSource and I'm relieved to know my blood is going to those in need. I never would have believed that my having HH could actually help save other lives."

About LifeSource

LifeSource, Chicagoland's non-profit blood center, is the largest supplier of blood and blood products in Illinois, and one of the largest blood centers in the country. Established in 1987 through a merger of the Blood Center of Northern Illinois and the American Red Cross Blood Services-Mid-America Region, LifeSource is owned and operated by The Institute for Transfusion Medicine (ITxM(SM)).

LifeSource operates 22 conveniently-located community donor centers, two mobile unit-supported donor centers, and conducts an average of 10 mobile blood drives daily (or 100 mobile blood drives weekly). Serving patients in six northern Illinois counties, LifeSource provides a half million blood products annually to approximately 60 hospitals - including 10 Level 1 Trauma Centers - in meeting the need for patient trans
'/>"/>

SOURCE LifeSource; Central Blood Bank
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. Leading-edge body sensor could help produce sporting champions
5. Hospital Quality Info on Web Can Be Misleading
6. AT&T Establishes New Network Services for Leading Medical Liability Insurer
7. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. Sentillion Positioned in Visionaries Quadrant in Leading Industry Analyst Firms User Provisioning Magic Quadrant
10. Leading Asthma and Allergy Author and Counselor Joins The HealthCentral Network As Expert
11. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... ... it comes to undergoing a hair transplant, most patients have donor hair moved from one ... the hair on top of the scalp, as well as filling in areas missing hair, ... on other areas of their head. , What about patients who have a limited, or ...
(Date:8/31/2015)... ... August 31, 2015 , ... India ... new “ InstantQuote ” tool, which summarizes all available plans, plan maximums, pre-existing ... tool is designed to help India Network members make an informed decision regarding ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... The Lisle ... Firm Partner William Scott has been nominated by his peers to earn a “Leading ... than five percent of attorneys in the state of Illinois. The nomination process is ...
(Date:8/31/2015)... New York, NY (PRWEB) , ... August 31, ... ... on Malignant Mesothelioma is a one-day event geared to patients and family ... and presented by local and regional mesothelioma experts. The conference is a collaborative ...
(Date:8/31/2015)... ... August 31, 2015 , ... CareSource, ... and Corporate Communications. In this capacity, Michael will provide strategic leadership for CareSource’s ... leader in consumer-focused programs that have contributed to the company’s rapid growth. As ...
Breaking Medicine News(10 mins):Health News:Body Hair Transplants to Help Achieve a Full Head of Hair 2Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:CareSource Names Vice President, Marketing and Corporate Communications 2
... first of its kind, designed to measure the safety ... deficit/hyperactivity disorder// (ADHD) with methylphenidate (Ritalin), has revealed that ... cause harm. The study also revealed that it is ... sensitive than older children to the side effects of ...
... explained the recent improvements in the treatment of amyotrophic lateral ... paralysis. It is observed that people with the disease die ... actually stop working. Despite all the claims, cure for ALS ... disease. ,During the study, human fetal stem cells ...
... crumbling under the mounting pressure of dengue. Safdarjung Hospital ... patients being referred to AIIMS and the Red Cross. ... are given platelets only on the condition of their ... for the required platelets. Dr Santosh at the Dengue ...
... has confirmed that herceptin, a drug used for treating ... criticism// over the decision. The deputy medical director of ... expensive and funding could not be justified. The recommendation ... arrived at after complete investigation of the evidence. ...
... some valuable information which would definitely help us to ... an autistic person is blue printed. ,One ... by autism a developmental disorder typically characterized by exhibiting ... ,Lead researcher Dr Michael Murias, from the University of ...
... closet, as a virulent breast cancer strain that can be ... Among the many types of breast cancer, HER2, an aggressive ... 5 women. , ,HER2, which represents the human epidermal ... particular gene that takes care of cell growth, division and ...
Cached Medicine News:Health News:Reduced Doses of Medication Beneficial to Preschoolers with ADHD 2Health News:Reduced Doses of Medication Beneficial to Preschoolers with ADHD 3Health News:Mounting Pressure of Dengue in Delhi Hospitals 2
(Date:8/31/2015)... Aug. 31, 2015  Asterias Biotherapeutics, Inc. (NYSE ... emerging field of regenerative medicine, today announced that ... Chicago -based Rush University Medical Center ... of escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) ... complete cervical spinal cord injury (SCI). This represents ...
(Date:8/31/2015)...   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue ... media and a related cloud hosted biologistics ... shippers ("BioLife" or the "Company"), today announced ... company focused on developing and commercializing novel therapeutics ...
(Date:8/28/2015)... JACKSONVILLE, Fla. , Aug. 28, 2015  With ... reaching deadlier heights, Jacksonville ... Philip Hemphill is helping to explain why ... Fentanyl is approximately 40 to 50 times more potent ... by recreational users as heroin, the risk of death ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
... use with the Moto Alpha unit, these new pads ... in which several successive runs may be sealed with ... to prevent a microplate from sticking to the block ... level of sealing performance, which means you can use ...
... Designed for use with the Moto Alpha unit, these ... cycle sequencing, in which several successive runs may be ... Alpha unit is engineered to prevent a microplate from ... pads provide an improved level of sealing performance, which ...
Microseal 'M' mats, seals 96-well plates, reusable, pkg of 10...
Omniseal TD mat. Reusable rubber mat for sealing PCR plates. 5 pk....
Medicine Products: